Clinical Study on Adjuvant Chemotherapy of Cinobufacin Injection in Senior Patients with Colorectal Cancer

To investigate the clinical efficacy of adjuvant chemotherapy of cinobufacin injection in the treatment of senior patients with colorectal cancer and its influence on serum tumor markers and immune function,from November 2018 to November 2019,84 senior colorectal cancer patients in author's hospital were al randomly divided into control group and observation group,42 cases in each group,and the control group was treated with routine chemotherapy,the observation group was treated with routine chemotherapy and intravenous injection of cinobufacin,the two groups were all treated for 4 cycles,then the short-term efficacy,serum tumor markers[carbohydrate antigen 19-9(CA19-9),carbohydrate antigen 724(CA724),carcinoembryonic antigen(CEA)]and immune function indexes(CD3+,CD4+,CD4+/CD8+),as well as the unward reaction of chemotherapy were compared between the two groups before and after treatment.As results,Short-term efficacy:the total effective rate of observation group was significantly higher than that of control group(78.57%vs 47.62%,P<0.05).Tumor markers:after treatment,the levels of CA19-9,CA724 and CEA in the two groups were significantly lower than those before treatment(P<0.05).Compared between the two groups,the levels of each index in observation group were lower(P<0.05).Immune function after treatment the levels of CD3+,CD4+,CD4+/CD8+in observation group were significantly higher than those before treatment while the levels of CD3+,CD4+,CD4+/CD8+in control group were significantly lower(P<0.05).After treatment,the above each index in observation group were higher than those in control group(P<0.05).Untoward reaction:the incidence of leukopenia,thrombocytopenia,gastrointestinal response,fatigue and myelosuppresion in observation group were significantly lower than those in control group(P<0.05).The results show that cinobufacin injection in the adjuvant treatment of senior patients with colorectal cancer can improve the shortterm efficacy of chemotherapy,reduce the untoward reaction,and reduce the serum levels of CA19-9,CA724 and CEA,improve the immune function of the body,thus with high clinical application value.

Finger millet porridges subjected to different processing conditions showed low glycemic index and variable efficacy on plasma antioxidant capacity of healthy adults

Finger millet porridges(FMP),rich in nutrient and non-nutrient compounds have been used in the traditional food cultures in Asia.The aims of the study were to determine the effect of different processing conditions of finger millet grains on glycemic response,phenolic content and the antioxidant activities of FMP and to determine the short term and long term efficacy of its consumption on plasma antioxidant levels of healthy adults.Twelve types of FMP were prepared combining different processing conditions.Phenolic content of porridges as well as antioxidant activities were determined.The glycemic index(GI)and glycemic load(GL)values of FMP were also evaluated.The long term efficacy of FMP consumption on plasma glucose(PG),total cholesterol(TC)levels and plasma antioxidant capacity(PAC)of 18 subjects were investigated using a 24 weeks randomized cross-over study.The short term efficacy of porridge consumption on AC was determined.PAC was measured by trolox equivalent antioxidant capacity(TEAC)and ferric ion reducing antioxidant power(FRAP).All FMP exhibited low GI values(<55)except the raw roasted flour which showed high and medium GI values for both particle sizes used.Parboiling of finger millet grains with 15 min steaming produced FMP with low glycemic response and possessed high PAC.Compared to baseline,PAC measured using FRAP and TEAC assays increased after 8 weeks consumption of porridge though significant changes were not observed for PG and TC levels.Furthermore,PAC was increased by 23 and 14%after 2 h of porridge consumption as measured by TEAC and FRAP,respectively.FMP consumption increased the plasma total antioxidant capacity of healthy adults.Further research on examining the potential of FMP on improving the antioxidant capacity in patients with diabetes is warranted.